Marinus Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Marinus Pharmaceuticals

13/08/2024 15:21

* Marinus Pharmaceuticals Inc  MRNS.OQ  reported a quarterly
adjusted loss of 60 cents​​ per share for the quarter ended in
June, higher than the same quarter last year, when the company
reported EPS of -61 cents.  The mean expectation of
eleven analysts for the quarter was for a loss of 59 cents per
share. Wall Street expected results to range from -68 cents
to -52 cents per share.
    * Revenue rose 32.2% to $8.04 million from a year ago;
analysts
expected $9.50 million. 
    * Marinus Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 63 cents​.
    * The company reported a quarterly loss of $35.83 million.
    * Marinus Pharmaceuticals Inc shares had risen by 5.1% this
quarter and lost 88.7% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Marinus
Pharmaceuticals Inc is $7.00 
This summary was machine generated from LSEG data August 13 at
02:21 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.59          -0.60          Missed
 Mar. 31 2024      -0.66          -0.68          Missed
 Dec. 31 2023      -0.62          -0.74          Missed
 Sep. 30 2023      -0.66          -0.61          Beat